Molecular basis for the antiparasitic activity of a mercaptoacetamide derivative that inhibits histone deacetylase 8 (HDAC8) from the human pathogen schistosoma mansoni.

Schistosomiasis, caused by the parasitic flatworm Schistosoma mansoni and related species, is a tropical disease that affects over 200 million people worldwide. A new approach for targeting eukaryotic parasites is to tackle their dynamic epigenetic machinery that is necessary for the extensive phenotypic changes during the life cycle of the parasite. Recently, we identified S. mansoni histone deacetylase 8 (smHDAC8) as a potential target for antiparasitic therapy. Here, we present results on the investigations of a focused set of HDAC (histone deacetylase) inhibitors on smHDAC8. Besides several active hydroxamates, we identified a thiol-based inhibitor that inhibited smHDAC8 activity in the micromolar range with unexpected selectivity over the human isotype, which has not been observed so far. The crystal structure of smHDAC8 complexed with the thiol derivative revealed that the inhibitor is accommodated in the catalytic pocket, where it interacts with both the catalytic zinc ion and the essential catalytic tyrosine (Y341) residue via its mercaptoacetamide warhead. To our knowledge, this is the first complex crystal structure of any HDAC inhibited by a mercaptoacetamide inhibitor, and therefore, this finding offers a rationale for further improvement. Finally, an ester prodrug of the thiol HDAC inhibitor exhibited antiparasitic activity on cultured schistosomes in a dose-dependent manner.

• Publication year

  2014

• Venue

  Journal of Molecular Biology

• Publication date

  2014-10-09

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jmb.2014.03.007PMID 24657767
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer's disease.

  2013cited by this paper
• Structural Basis for the Inhibition of Histone Deacetylase 8 (HDAC8), a Key Epigenetic Player in the Blood Fluke Schistosoma mansoni

  2013influential reference
• Schistosoma mansoni Sirtuins: Characterization and Potential as Chemotherapeutic Targets

  2013influential reference
• Whole-genome sequence of Schistosoma haematobium

  2012cited by this paper
• Chiral Mercaptoacetamides Display Enantioselective Inhibition of Histone Deacetylase 6 and Exhibit Neuroprotection in Cortical Neuron Models of Oxidative Stress

  2012cited by this paper
• Inhibitors of the NAD(+)-Dependent Protein Desuccinylase and Demalonylase Sirt5.

  2012cited by this paper
• Crebinostat: a novel cognitive enhancer that inhibits histone deacetylase activity and modulates chromatin-mediated neuroplasticity.

  2012cited by this paper
• A Systematically Improved High Quality Genome and Transcriptome of the Human Blood Fluke Schistosoma mansoni

  2012cited by this paper
• Operating on chromatin, a colorful language where context matters.

  2011cited by this paper
• Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma

  2011cited by this paper
• Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors.

  2011cited by this paper
• Deciphering correct strategies for multiprotein complex assembly by co-expression: application to complexes as large as the histone octamer.

  2011cited by this paper
• Structural basis of the antiproliferative activity of largazole, a depsipeptide inhibitor of the histone deacetylases.

  2011cited by this paper
• Chromatin structure and the inheritance of epigenetic information

  2010cited by this paper
• The genome of the blood fluke Schistosoma mansoni

  2009cited by this paper
• Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.

  2009cited by this paper
• Cloning, molecular characterization of a 13-kDa antigen from Schistosoma japonicum, Sj13, a putative salivary diagnosis candidate for Schistosomiasis japonica

  2009cited by this paper
• Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility.

  2009cited by this paper
• MolProbity: all-atom structure validation for macromolecular crystallography

  2009cited by this paper
• Destabilization of ERBB2 Transcripts by Targeting 3′ Untranslated Region Messenger RNA Associated HuR and Histone Deacetylase-6

  2008cited by this paper
• The class I histone deacetylases of the platyhelminth parasite Schistosoma mansoni.

  2008cited by this paper
• Interferon-α is able to maintain complete molecular remission induced by imatinib after its discontinuation

  2008cited by this paper
• Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8–substrate complex

  2007cited by this paper
• Immunopathology of schistosomiasis

  2007cited by this paper
• Chromatin modifications and their function.

  2007cited by this paper
• The Research Collaboratory for Structural Bioinformatics Protein Data Bank

  2007cited by this paper
• Functional differences in epigenetic modulators-superiority of mercaptoacetamide-based histone deacetylase inhibitors relative to hydroxamates in cortical neuron neuroprotection studies.

  2007cited by this paper
• Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition.

  2006cited by this paper
• Carbonyl- and sulfur-containing analogs of suberoylanilide hydroxamic acid: Potent inhibition of histone deacetylases.

  2006cited by this paper
• Schistosoma mansoni CBP/p300 has a conserved domain structure and interacts functionally with the nuclear receptor SmFtz-F1.

  2006cited by this paper
• Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance

  2006cited by this paper
• In vitro assays for the determination of histone deacetylase activity.

  2005cited by this paper
• Identification of a potent non-hydroxamate histone deacetylase inhibitor by mechanism-based drug design.

  2005cited by this paper
• Chemistry and biology of mercaptoacetamides as novel histone deacetylase inhibitors.

  2005cited by this paper
• Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SAHA-based non-hydroxamates.

  2005cited by this paper
• Coot: model-building tools for molecular graphics.

  2004cited by this paper
• Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT.

  2004cited by this paper
• Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code

  2003cited by this paper
• Novel histone deacetylase inhibitors: N-hydroxycarboxamides possessing a terminal bicyclic aryl group.

  2002cited by this paper
• Resistance of Schistosoma mansoni to praziquantel: is there a problem?

  2002cited by this paper
• Translating the Histone Code

  2001cited by this paper
• Correspondence e-mail:

  2000cited by this paper
• Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation.

  1999cited by this paper
• Development and validation of a genetic algorithm for flexible docking.

  1997cited by this paper
• [20] Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• The synthesis of N-hydroxy-N'-phenyloctanediamide and its inhibitory effect on proliferation of AXC rat prostate cancer cells.

  1995cited by this paper
• FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity.

  1994cited by this paper
• Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase.

  1993cited by this paper
• Schistosoma mansoni: defined system for stepwise transformation of cercaria to schistosomule in vitro.

  1974cited by this paper
• Chromatin Modifications and Their Function

  year unknowncited by this paper
• Electronic Reprint Biological Crystallography Phenix : a Comprehensive Python-based System for Macromolecular Structure Solution

  year unknowncited by this paper

• N-Aryl-S-aryl-2-mercaptoacetamide Derivatives Effectively Inhibit Mushroom and Cellular Tyrosinase Activities, Melanin Production, and Pigmentation in Zebrafish Larvae: Regarding Copper Ion Chelation

  2026cites this paper
• Drug Discovery for Histone Deacetylase Inhibition: Past, Present and Future of Zinc-Binding Groups

  2025cites this paper
• Establishing a noncanonical zinc-binding group as a selective histone deacetylase inhibitor and possible novel anticancer agent.

  2025cites this paper
• Ligand-Based Virtual Screening and QSAR Modelling for the Discovery of Potent SmHDAC8 Inhibitors

  2025cites this paper
• Structure-Activity Studies of 1,2,4-Oxadiazoles for the Inhibition of the NAD+-Dependent Lysine Deacylase Sirtuin 2.

  2024cites this paper
• Overview of class I HDAC modulators: Inhibitors and degraders.

  2024cites this paper
• Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases

  2024cites this paper
• Histone deacetylase (HDAC) inhibitor specificity determinants are preserved in a class of dual HDAC/non-covalent proteasome inhibitors.

  2024cites this paper
• Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer.

  2023cites this paper
• Luteolin attenuates diabetic nephropathy via inhibition of metalloenzymes in rats

  2023cites this paper
• HDAC inhibitors rescue MeCP2T158M speckles in a high content screen

  2023cites this paper
• The Zinc-Binding Group Effect: Lessons from Non-Hydroxamic Acid Vorinostat Analogs.

  2023cites this paper
• Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis

  2022cites this paper
• Chemically Diverse S. mansoni HDAC8 Inhibitors Reduce Viability in Worm Larval and Adult Stages

  2022cites this paper
• The Effect of Short-Chain Fatty Acids on Growth of Cryptosporidium parvum In Vitro

  2022cites this paper
• A detail survey and analysis of selectivity criteria for indole-based histone deacetylase 8 (HDAC8) inhibitors

  2022cites this paper
• Crystal structures of Schistosoma mansoni histone deacetylase 8 reveal a novel binding site for allosteric inhibitors

  2022cites this paper
• Aryl-n-hexanamide linked enaminones of usnic acid as promising antimicrobial agents

  2022cites this paper
• Strategies To Design Selective Histone Deacetylase Inhibitors

  2021cites this paper
• Non-Hydroxamate Zinc-Binding Groups as Warheads for Histone Deacetylases

  2021cites this paper
• Binding Free Energy (BFE) Calculations and Quantitative Structure–Activity Relationship (QSAR) Analysis of Schistosoma mansoni Histone Deacetylase 8 (smHDAC8) Inhibitors

  2021cites this paper
• The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs

  2021cites this paper
• Gestation and breastfeeding in schistosomotic mice differentially alters the expression of histone deacetylases (HDACs) in adult offspring

  2020cites this paper
• New Chemicals for Sheep Blowfly Control

  2020cites this paper
• Mercaptoacetamide: A promising zinc-binding group for the discovery of selective histone deacetylase 6 inhibitors.

  2020influential citation
• Discovery of thieno[2,3-d]pyrimidine based hydroxamic acid derivatives as bromodomain-containing protein 4/histone deacetylases dual inhibitors induce autophagic cell death in colorectal carcinoma cells.

  2020cites this paper
• Screening and phenotypical characterization of Schistosoma mansoni histone deacetylase 8 (SmHDAC8) inhibitors as multi-stage antischistosomal agents.

  2020cites this paper
• Structure‐Based Design, Synthesis, and Biological Evaluation of Triazole‐Based smHDAC8 Inhibitors

  2019cites this paper
• Structure, mechanism, and inhibition of the zinc-dependent histone deacetylases.

  2019cites this paper
• Target Identification of HDAC8 Isoform for the Treatment of Cancer

  2019cites this paper
• Structural Biology of Epigenetic Targets: Exploiting Complexity

  2019cites this paper
• Parasite Epigenetic Targets

  2019cites this paper
• A Tiny Change Makes a Big Difference in the Anti-Parasitic Activities of an HDAC Inhibitor

  2019cites this paper
• Structure-Reactivity Relationships on Substrates and Inhibitors of the Lysine Deacylase Sirtuin 2 from Schistosoma Mansoni (SmSirt2).

  2019cites this paper
• Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants.

  2018cites this paper
• Computational quantum chemistry, molecular docking, and ADMET predictions of imidazole alkaloids of Pilocarpus microphyllus with schistosomicidal properties

  2018cites this paper
• Synthesis of aminophenylhydroxamate and aminobenzylhydroxamate derivatives and in vitro screening for antiparasitic and histone deacetylase inhibitory activity

  2018cites this paper
• A New and Economic Synthesis of Crebinostat

  2018cites this paper
• A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro Testing

  2018cites this paper
• Compounds from African Medicinal Plants with Activities against Protozoal Diseases: Schistosomiasis, Trypanosomiasis and Leishmaniasis

  2018cites this paper
• Inhibition of histone methyltransferase EZH2 in Schistosoma mansoni in vitro by GSK343 reduces egg laying and decreases the expression of genes implicated in DNA replication and noncoding RNA metabolism

  2018cites this paper
• Compounds from African Medicinal Plants with Activities Against Selected Parasitic Diseases: Schistosomiasis, Trypanosomiasis and Leishmaniasis

  2018cites this paper
• Molecular Basis for the Selective Inhibition of Histone Deacetylase 6 by a Mercaptoacetamide Inhibitor.

  2018cites this paper
• Synthesis, Crystallization Studies, and in vitro Characterization of Cinnamic Acid Derivatives as SmHDAC8 Inhibitors for the Treatment of Schistosomiasis

  2018cites this paper
• 5.23 – Antiparasitic Agents

  2017cites this paper
• Structure-activity relationships of hydroxamate-based histone deacetylase-8 inhibitors: reality behind anticancer drug discovery.

  2017cites this paper
• Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives.

  2017cites this paper
• Structural insights of SmKDAC8 inhibitors: Targeting Schistosoma epigenetics through a combined structure-based 3D QSAR, in vitro and synthesis strategy.

  2017cites this paper
• Comparative pattern of growth and development of Echinostoma paraensei (Digenea: Echinostomatidae) in hamster and Wistar rat using light and confocal laser scanning microscopy.

  2017cites this paper
• The Compatibility Between Biomphalaria glabrata Snails and Schistosoma mansoni: An Increasingly Complex Puzzle.

  2017cites this paper
• Post-translational Modifications of Trypanosoma cruzi Canonical and Variant Histones.

  2017cites this paper
• Analysis of the interactome of Schistosoma mansoni histone deacetylase 8

  2017cites this paper
• Isophthalic Acid‐Based HDAC Inhibitors as Potent Inhibitors of HDAC8 from Schistosoma mansoni

  2017cites this paper
• Evolutionary relationships among protein lysine deacetylases of parasites causing neglected diseases.

  2017cites this paper
• Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis.

  2016cites this paper
• Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseases.

  2016cites this paper
• Large-Scale Overproduction and Purification of Recombinant Histone Deacetylase 8 (HDAC8) from the Human-Pathogenic Flatworm Schistosoma mansoni.

  2016cites this paper
• Combattre les maladies négligées en ciblant sélectivement leurs enzymes épigénétiques : le cas de la désacétylase 8 (HDAC8) de Schistosoma mansoni

  2016cites this paper
• Discovery of Novel Antischistosomal Agents by Molecular Modeling Approaches.

  2016cites this paper
• Targeting the Bromome: are we there yet?

  2016cites this paper
• HDAC8: a multifaceted target for therapeutic interventions.

  2015cites this paper
• Drugging the schistosome zinc-dependent HDACs: current progress and future perspectives.

  2015cites this paper
• Homology modeling of parasite histone deacetylases to guide the structure-based design of selective inhibitors.

  2015cites this paper
• The Specificity and Regulation of Human Histone Deacetylase 8.

  2015cites this paper
• Central German Meeting on Bioinformatics 2015

  2015cites this paper
• Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites

  2015cites this paper
• Fluorescence-Based Screening Assays for the NAD+-Dependent Histone Deacetylase smSirt2 from Schistosoma mansoni

  2015cites this paper
• Targeting Lysine Deacetylases (KDACs) in Parasites

  2015cites this paper
• Discovery of Inhibitors of Schistosoma mansoni HDAC8 by Combining Homology Modeling, Virtual Screening, and in Vitro Validation

  2014cites this paper
• Zooming into epigenetic regulatory elements in health and disease.

  2014cites this paper
• Epigenetic control of gene function in schistosomes: a source of therapeutic targets?

  2014cites this paper